Objective. —To compare efficacy and safety of tacrine hydrochloride with placebo in
patients with probable Alzheimer's disease. Design. —A 12-week, double-blind, placebo-controlled, …

Background LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular
disease. How much one should or safely can lower this risk factor remains debated. We …

The frequent co-occurrence of Alzheimer’s disease (AD) pathology in patients with normal
pressure hydrocephalus suggests a possible link between ventricular dilation and AD. If …

Background Findings from clinical trials of proprotein convertase subtilisin–kexin type 9 (PCSK9)
inhibitors have led to concern that these drugs or the low levels of low-density …

Objective: The goal of this study was to define the natural progression of driving impairment
in persons who initially have very mild to mild dementia. Methods: We studied 128 older …

Objective The objective of this study was to compare the efficacy and safety of the moderate-affinity,
uncompetitive N-methyl-d-aspartate receptor antagonist, memantine, versus placebo …

BACKGROUND In 2012, the United States Food and Drug Administration (FDA) issued a
warning regarding potential adverse effects of HMG-CoA reductase inhibitors (statins) on …

This study examined the relation between awareness of memory and functional decline and
cognitive function in patients with Alzheimer disease (AD). Twentysix patients with early AD …

Background Prior studies on Quality of Life (QOL) in Alzheimer's disease (AD) have rarely
included control participants, or participants with very mild levels of cognitive impairment. …

Over the past 10 years, several instruments developed specifically for the assessment of
Quality of Life (QOL) in dementia have been introduced. The goal of the current review is to …